Logo

Nath Bio-Genes Share Price

Nath Bio-Genes (INR)172.87-5.7   (-3.2%)

Exchange ScripsBSE537291NSENATHBIOGENISININE448G01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Nath Bio-Genes Performance

Market performance
Open price181.89
High181.89
Volumes17432
Prev Close172.87
Low171.1
Closing date2025-01-10
Historical performance
1 Year High264.31
3 Year High288.50
5 Year High473.95
1 Year Low167.15
3 Year Low128.85
5 Year Low127.30

Nath Bio-Genes Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
326
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
8.29
Dividend Yield
Dividend Yield
0.12 %

Nath Bio-Genes Investment Returns

1 Year
-18.3%
3 Years
-36.4%
5 Years
-51%
10 Years
37.7%

Nath Bio-Genes Technicals

IndicatorsValueSignal
5-DMA179.48Bearish
10-DMA183.94Bearish
20-DMA187.64Bearish
50-DMA188.33Bearish
100-DMA201.04Bearish
200-DMA205.19Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1616161717
Foreign Investors---------------
Domestic Investors1616161717
Public Investors3540735818351163424634348
Government---------------

Nath Bio-Genes Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Other Income6619
Operating Profit506495391
Interest92104106
Depreciation333031
Profit Before Tax416362-634
Consolidated Net Profit396350-674
Adjusted EPS2118-35

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Share Capital190190190
Total Reserves590955425229
Minority Interest---------
Total Non-Current Liabilities793233
Total Liabilities880279287395
Capital Work in Progress---------
Total Assets880279287395

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Cash Flow from Operating Activities746384170
Cash Flow from Investing Activities-274-29-199
Cash Flow from Financing Activitie-78-17-222
Net Cash Inflow / Outflow394338-250
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 8.29.
  • 3Y Stock Price CAGR of the stock is -13.2.
  • The stock has a beta of 1.2.
  • In the last financial year, the company had an EBITDA of ₹506 Million.
  • The company generated revenue of ₹3326 Million in the previous financial year.

Nath Bio-Genes

172.87-5.7   (-3.2%)

Investment Amount: ₹ 21265
Current Value: ₹ 17287
Performance: -18.7%
P/L: ₹ -3978
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Narmada Agrobase

30.5

21.34

December 12 - January 12

Mangalam Global Ent

21

28.61

December 12 - January 12

Harrisons Malayalam

3.9

284.45

December 12 - January 12

Kaveri Seed

-4.1

908.5

December 12 - January 12

Venkys India

-6.6

1701.85

December 12 - January 12

Agri-Tech (India)

-9.3

185.48

December 12 - January 12

Bombay Super Hybrid

-12.2

141.45

December 12 - January 12

Bombay Burmah Trdg.

-16.5

2006.65

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month